KaloCyte
kalocyte.com
Biotechnology
Claim pageClaim
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Grants
$7.7M
6 grants · CORDIS
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Aug 14, 2025
Won a grant $1.8M · CORDIS
Jun 1, 2023
Won a grant $3M · CORDIS
Aug 1, 2021
Won a grant $500k · CORDIS
May 1, 2020
Won a grant $373k · CORDIS
Jun 15, 2018
Won a grant $1.6M · CORDIS
May 11, 2017
Won a grant $398k · CORDIS
Funding rounds
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
The future of medicine is in our blood. Scarlet Therapeutics is developing a pioneering platform that generates novel red blood cell-based…
Leuko is developing PointCheck™, the first noninvasive device for monitoring white blood cell levels at home, without a blood draw.
FROM CELLS TO ORGANELLES• ORGANELLES•. First-in-Class Isolated Organelles for Drug Discovery.
Developing intravenous recombinant human decorin to treat dystrophic epidermis bullosa.. Kamal Therapeutics, Inc.
Paloma offers a new way to treat and monitor hypothyroidism. Get your blood tests, medical guidance and prescriptions online from the best…
Cayuga Biotech is developing novel therapies to address life-threatening hemorrhage byharnessing the body’s innate ability to stop bleeding.
Overview
KaloCyte is developing ErythroMer™, a dried, bio-inspired artificial red blood cell, to treat life-threatening blood loss when stored red blood cells are unavailable, undesirable or in short supply.
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Baltimore
United States
HQ